1st Quarter - Report

COVINGTON & BURLING LLP for 1776 PHARMACEUTICALS LLC

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Re-shoring production of essential medicine

Foreign entity interest: Foreign entities identified on form LD-1 have an interest in the lobbying issues.

LobbyistCovered position, as disclosed
HOWARD BERMAN —
LAYTH SAMI ELHASSANI —
GARY HEIMBERG —
BRODERICK JOHNSON —
JOAN KUTCHER —
MUFTIAH MCCARTIN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Manufacturing MAN

Re-shoring production of essential medicine

Foreign entity interest: Foreign entities identified on form LD-1 have an interest in the lobbying issues.

LobbyistCovered position, as disclosed
HOWARD BERMAN —
LAYTH SAMI ELHASSANI —
GARY HEIMBERG —
BRODERICK JOHNSON —
JOAN KUTCHER —
MUFTIAH MCCARTIN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Pharmacy PHA

Re-shoring production of essential medicine

Foreign entity interest: Foreign entities identified on form LD-1 have an interest in the lobbying issues.

LobbyistCovered position, as disclosed
HOWARD BERMAN —
LAYTH SAMI ELHASSANI —
GARY HEIMBERG —
BRODERICK JOHNSON —
JOAN KUTCHER —
MUFTIAH MCCARTIN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.